TEFAF Oncology Chair

General information

In 2005 the Board of the TEFAF decided to support medical cancer research by appointing a personal chair in the field of Oncology at the University Hospital Maastricht (azM) and the Faculty of Health, Medicine and Life Sciences. The visiting (international) professor will stimulate both the current medical research and training of doctors and researchers, as well as broaden knowledge and skills, also in the Euregion Meuse-Rhine. The visiting professor will function within GROW - School for Oncology and Developmental Biology.

Composition of the Supervisory Council:
President of TEFAF
Scientific Director of GROW
Dean of the Faculty of Health, Medicine and Life Sciences Maastricht University

The Supervisory Council has been formed to guide the selection procedure for this TEFAF Oncology chair and to perform an evaluation on a yearly basis.


Prof.dr. Christopher Paul Wild

Dr. Christopher Paul Wild has been appointed as Visiting Professor and TEFAF Chair of Oncology for 2018.
Since 2009 he is  the Director of the International Agency for Research on Cancer (IARC), the specialized cancer agency of the World Health Organization.
Dr. Wild has published many important studies on the role of environmental and dietary factors as a cause of cancer. The main research interest of Dr. Wild is to understand the interplay between environmental and genetic risk factors in the causation of human cancer. He therefore proposed the concept of the “exposome” and studies its interaction with the genome. The exposome concept refers to the totality of environmental exposures from preconception onwards, and is a novel approach to studying the role of gene-environment interactions in the development of human disease.

March 15, 2018

Programme Symposium'The Exposome and Cancer Prevention'
Invitation Inauguration
video inauguration


Prof. dr. Jan Hoeijmakers

Prof. dr. Jan Hoeijmakers

Professor Jan Hoeijmakers has been appointed as Visiting Professor at this Chair of Oncology for 2017. He has published many important studies on the role of DNA repair in cancer and aging, and his accomplishments have been internationally recognized. 

Click here for the interview in Observant (only in Dutch).

January 12, 2018

College Tour 'Shaping your Career in Biomedical Sciences'
personal invitation from Jan and Martijn
Photographic impression; ps://photos.google.com/?hl=nl
Video impression; https://youtu.be/_9c6xinysT4

March 16, 2017

Programme Master Class
Photographic impression Master Class
Video: Welcome by Prof. dr. Frans Ramaekers
Video: Lecture ""Missing mismatch repair: Strategies for clinical management of the intestinal cancer predisposition Lynch syndrome” by Prof. dr. Hein ten Riele
Video: Lecture “Dissecting the repair of DNA interstrand crosslinks; DNA lesions that can cause and cure cancer"by Dr. Puck Knipscheer
Video: Lecture "Targeting DNA double strand break repair pathways to optimize anti-tumor therapy"by Dr. Dik van Gent
Video: Lecture “Cellular responses to DNA double strand breaks: Molecular mechanisms and clinical utility” by Prof. dr. Roland Kanaar
Invitation inauguration
Photographic impression Inauguration
Video: Inauguration “Keeping your genome intact protects from cancer and aging" Prof. dr. Jan Hoeijmakers 
Video: slides Inauguration “Keeping your genome intact protects from cancer and aging" Prof. dr. Jan Hoeijmakers


Prof. dr. C. Figdor 

Professor Carl Figdor has been appointed as Visiting Professor at this Chair of Oncology for 2016. He has published many important studies in the field of tumor immunology and his accomplishments have been internationally recognized. 
The objective of attracting visiting professors is to cement  Maastricht’s oncology research with highly recognized national and international research teams, which raises cancer research and finally cancer treatment to a higher level. The TEFAF Oncology Chair provides a strong impuls to achieve such (inter)national cooperations.

Click here for the interview in Observant (only in Dutch).

March 17, 2016

Programme Master Class
Photographic impression Master Class
Invitation inauguration
Photographic impression Inauguration 
Video: welcome by Prof. F. Ramaekers
Video: lecture “The dichotomy of tumor-promoting and tumor-antagonizing immune responses” by Prof. D. Hanahan
Video: lecture “Restoring immunosurveillance by dendritic cell vaccines and manipulation of the tumor microenvironment” by Prof. dr. J. de Vries
Lecture “The immunoregulatory role of neutrophils in disease progression and therapy resistance of melanoma” by Prof. dr. T. Tüting (no video available)
Video: lecture “Natural killer cells: the secret weapon in dendritic cell vaccination strategies” by dr. W. Germeraad
Video: lecture “Tryptophan-degrading enzymes in tumoral immune resistance” by Prof. dr. B. van den Eynde
Video: lecture "Targeting or reprogramming tumor macrophages for anticancer therapy" by dr. M. de Palma
Video: lecture “Metabolic communication and competition: why T cells fight and cooperate in tumors” by dr. P. Ho
Video: inaugural lecture “Making of the immune system: a glimpse into the future” by Prof. C. Figdor


Prof. Douglas Hanahan, Full Professor, EPFL

Doug Hanahan

Prof. Douglas Hanahan is Director of the Swiss Institute for Experimental Cancer Research (Institut Suisse de Recherche Expérimentale sur le Cancer, ISREC), and Professor of Molecular Oncology in the School of Life Sciences at the Swiss Federal Institute of Technology Lausanne (Ecole Polytechnique Fédérale de Lausanne, EPFL). Hanahan received a bachelor’s degree in Physics from the Massachusetts Institute of Technology (MIT) in 1976, and a Ph.D. in Biophysics from Harvard University in 1983, where he was elected to the prestigious position of Junior Fellow of the Harvard Society of Fellows.  He worked at the legendary Cold Spring Harbor Laboratory in New York first as a graduate student and then as a faculty member. Subsequently he spent twenty years as a Professor in the preeminent University of California at San Francisco before moving to EPFL in 2009. Hanahan’s accomplishments have been recognized by his election to several honorific societies, as a Fellow in the American Academy of Arts & Sciences (2007), and as a member of the Institute of Medicine of the US National Academies (2008), of the US National Academy of Science (2009), and of the European Molecular Biology Organization (2010).

March 20, 2015

Programme Master Class
Photographic impression Master Class
Invitation inauguration
Photographic impression Inauguration

Article in Observant, dated February 5, 2015

> Read more